Study on Dynamic Changes and Correlation of Serum Levels of Transforming Growth Factor β1 and Radiation-induced Hepatic Fibrosis in Rat
Wang Yun-lia
Abstract
Wang Yun-lia
Abstract
Objective: Radiation therapy of liver carcinoma may lead to the complication of radiation- induced liver disease(RILD), hepatic fibrosis, even hepatic cirrhosis. So it is of great significance to look for better serum markers for noninvasively diagnosing and monitoring radiation-induced hepatic fibrosis. In this study, we established the rats model of radiation-induced hepatic fibrosis,detected the dynamic changes of serum levels of transforming growth factor beta 1(TGF-β1), explored the correlation of TGF-β1 and the severity of radiation-induced hepatic fibrosis, and discovered the diagnosis value of TGF-β1. Methods: Forty healthy male Sprague-Dawley rats were randomly divided into model group(30 rats) and control group(10 rats). The right-half of rat liver in model group was irradiated with a single dose of 25 Gy to establish radiation-induced hepatic fibrosis model. Liver tissues from the irradiated liver, and blood sample were collected at different time points(2 months, 4 months, 6 months) after irradiation. Expression of TGF-β1 by enzyme-linked immunosorbent assay(ELISA) was performed. Pathomorphological change in the liver was observed with hematoxylineosin staining by optical microscope. Results: The expression of serum TGF-β1 of model group at different time points [2 months,(551.03±69.00) ng/L; 4 months,(645.31±109.29) ng/L; 6 months,(737.89±118.11) ng/L] was significantly higher than that of the control group(451.71±51.12 ng/L, P0.05). There were distinctly positive correlation between the serum of TGF-β1 value and severity of hepatic fibrosis(r=0.82, P0.01). Conclusion: In the development of radiation- induced fibrosis, TGF-β1 rises with the severity of hepatic fibrosis. We provide a new noninvasive and convenient means for monitoring the severity of hepatic fibrosis, and lay a theoretical foundation for subsequent TGF-β1 as a serum marker applied to clinical research of radiation-induced hepatic fibrosis.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: Radiation therapy of liver carcinoma may lead to the complication of radiation- induced liver disease(RILD), hepatic fibrosis, even hepatic cirrhosis. So it is of great significance to look for better serum markers for noninvasively diagnosing and monitoring radiation-induced hepatic fibrosis. In this study, we established the rats model of radiation-induced hepatic fibrosis,detected the dynamic changes of serum levels of transforming growth factor beta 1(TGF-β1), explored the correlation of TGF-β1 and the severity of radiation-induced hepatic fibrosis, and discovered the diagnosis value of TGF-β1. Methods: Forty healthy male Sprague-Dawley rats were randomly divided into model group(30 rats) and control group(10 rats). The right-half of rat liver in model group was irradiated with a single dose of 25 Gy to establish radiation-induced hepatic fibrosis model. Liver tissues from the irradiated liver, and blood sample were collected at different time points(2 months, 4 months, 6 months) after irradiation. Expression of TGF-β1 by enzyme-linked immunosorbent assay(ELISA) was performed. Pathomorphological change in the liver was observed with hematoxylineosin staining by optical microscope. Results: The expression of serum TGF-β1 of model group at different time points [2 months,(551.03±69.00) ng/L; 4 months,(645.31±109.29) ng/L; 6 months,(737.89±118.11) ng/L] was significantly higher than that of the control group(451.71±51.12 ng/L, P0.05). There were distinctly positive correlation between the serum of TGF-β1 value and severity of hepatic fibrosis(r=0.82, P0.01). Conclusion: In the development of radiation- induced fibrosis, TGF-β1 rises with the severity of hepatic fibrosis. We provide a new noninvasive and convenient means for monitoring the severity of hepatic fibrosis, and lay a theoretical foundation for subsequent TGF-β1 as a serum marker applied to clinical research of radiation-induced hepatic fibrosis.
Key concepts: Cirrhosis, Hepatic fibrosis, Medicine, Fibrosis, Internal medicine, Transforming growth factor, Hepatocellular carcinoma, Pathology